Zogenix which recently IPO'd for $4 is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Our first commercial product, Sumavel™ DosePro™ (sumatriptan injection) Needle-free Delivery System, was launched in January 2010. Sumavel DosePro offers fast-acting, easy-to-use, needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache in a pre-filled, single-use delivery system. They recently got approval in Denmark for the needle-free version of the migraine treatment sumatriptan.
Opinion & investing ideas
dimanche 5 décembre 2010
ZGNX sur la watch list
Zogenix which recently IPO'd for $4 is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Our first commercial product, Sumavel™ DosePro™ (sumatriptan injection) Needle-free Delivery System, was launched in January 2010. Sumavel DosePro offers fast-acting, easy-to-use, needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache in a pre-filled, single-use delivery system. They recently got approval in Denmark for the needle-free version of the migraine treatment sumatriptan.
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire